首页> Annals of oncology : official journal of the European Society for Medical Oncology> Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

导出 LinkOut

翻译打印收藏纠错

第一作者： A D,Wagner

第一单位： First Department of Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. Electronic address: anna-dorothea.wagner@gmx.de.

作者： A D,Wagner ^[1] ; P,Buechner-Steudel ^[2] ; A,Wein ^[3] ; H,Schmalenberg ^[4] ; U,Lindig ^[4] ; M,Moehler ^[5] ; R,Behrens ^[6] ; G,Kleber ^[2] ; O,Kuss ^[7] ; W E,Fleig ^[2]

作者单位： First Department of Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. Electronic address: anna-dorothea.wagner@gmx.de. ^[1] First Department of Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. ^[2] First Department of Medicine, Friedrich-Alexander-University Erlangen, Erlangen, Germany. ^[3] Department of Medicine II, Friedrich-Schiller-University, Jena, Germany. ^[4] First Department of Medicine, Johannes-Gutenberg-University Mainz, Mainz, Germany. ^[5] Gastroenterology Practice, Halle (Saale), Germany. ^[6] Institute of Medical Epidemiology, Biostatistics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany. ^[7]